|
|
Article: Dana-Farber Cancer Institute Extends Value of Clinical and Research Data With Oracle.
- Article from:
- PR Newswire
- Article date:
- August 4, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Oracle(R) Healthcare Transaction Base and Oracle Fusion Middleware Form Foundation for Translational Research Infrastructure Created to Improve Disease Understanding and Treatment
REDWOOD SHORES, Calif., Aug. 4 /PRNewswire-FirstCall/ -- -- Dana-Farber Cancer Institute, one of the leading cancer research and care centers in the United States, is using Oracle(R) Healthcare Transaction Base (HTB) and Oracle Fusion Middleware components as the foundation for its new translational research infrastructure.
-- The new infrastructure is designed to maximize the value of clinical and research data, and help improve disease understanding and patient care.